peptide microarray Search Results


94
KCAS Bioanalytical and Biomarker Services electrodes
Electrodes, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/electrodes/product/KCAS Bioanalytical and Biomarker Services
Average 94 stars, based on 1 article reviews
electrodes - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

93
KCAS Bioanalytical and Biomarker Services liquid chromatography
Liquid Chromatography, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/liquid chromatography/product/KCAS Bioanalytical and Biomarker Services
Average 93 stars, based on 1 article reviews
liquid chromatography - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

99
KCAS Bioanalytical and Biomarker Services kcas bio analytical
Kcas Bio Analytical, supplied by KCAS Bioanalytical and Biomarker Services, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kcas bio analytical/product/KCAS Bioanalytical and Biomarker Services
Average 99 stars, based on 1 article reviews
kcas bio analytical - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

90
Arrayit Corporation protein microarray kit
Protein Microarray Kit, supplied by Arrayit Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein microarray kit/product/Arrayit Corporation
Average 90 stars, based on 1 article reviews
protein microarray kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
JPT Peptide Technologies GmbH peptide microarrays pepstar
Peptide Microarrays Pepstar, supplied by JPT Peptide Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide microarrays pepstar/product/JPT Peptide Technologies GmbH
Average 90 stars, based on 1 article reviews
peptide microarrays pepstar - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh peptide microarray
Peptide Microarray, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide microarray/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
peptide microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
JPT Peptide Technologies GmbH peptide microarray
Peptide Microarray, supplied by JPT Peptide Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide microarray/product/JPT Peptide Technologies GmbH
Average 90 stars, based on 1 article reviews
peptide microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh pepperchip© custom peptide microarray
Pepperchip© Custom Peptide Microarray, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pepperchip© custom peptide microarray/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
pepperchip© custom peptide microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Pepscan Inc spike protein peptide microarray
a Antibody-mediated neutralization of infection of luciferase-encoding VSV particles pseudotyped with spike proteins of MERS-CoV, SARS-CoV, SARS-CoV-2 and HCoV-OC43. Pseudotyped VSV particles pre-incubated with antibodies at indicated concentrations were used to infect VeroCCL81 cells (MERS-S pseudotyped VSV), VeroE6 cells (SARS-S and SARS2-S pseudotyped VSV) or HRT-18 cells (OC43-S pseudotyped VSV) and luciferase activities in cell lysates were determined at 20 h post transduction to calculate infection (%) relative to non-antibody-treated controls. The average ± SD ( n ≥ 6) from at least two independent experiments performed is shown. Iso-CTRL: an anti-Strep-tag human monoclonal antibody was used as an antibody isotype control. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. b Antibody-mediated neutralization of MERS-CoV, SARS-CoV and SARS-CoV-2 infection. Neutralization of authentic viruses was performed using a plaque reduction neutralization test (PRNT) on VeroCCL81 cells (MERS-CoV) or VeroE6 (SARS-CoV and SARS-CoV-2) as described earlier  ,  . The experiment was performed with triplicate samples, the average ± SD is shown. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. c ELISA-based receptor-binding inhibition assay. MERS-S ecto pre-incubated with serially diluted mAbs was added to ELISA plates coated with soluble human DPP4. The binding of MERS-S ecto to DPP4 was detected using an HRP-conjugated antibody recognizing the C-terminal Strep-tag on MERS-S ecto . Data points represent the average ± SD, for n = 3 replicates from two independent experiments. Source data are provided as a Source Data file. d Cell-cell fusion inhibition assay. Huh-7 cells—transfected with plasmid expressing (GFP-tagged) MERS-CoV S were pre-incubated in the presence or absence of 1.6C7 and 28D9, or an irrelevant iso-type control antibody (Iso-CTRL), and then treated with trypsin to activate the membrane fusion function of the MERS-CoV S protein. The formation of MERS-S mediated syncytia was visualized by fluorescence microscopy. Merged images of MERS-S-GFP expressing cells (green) and DAPI-stained cell nuclei (blue) are shown. The experiment was performed twice, data from a representative experiment is shown. Source data are provided as a Source Data file.
Spike Protein Peptide Microarray, supplied by Pepscan Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spike protein peptide microarray/product/Pepscan Inc
Average 90 stars, based on 1 article reviews
spike protein peptide microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Fluorous Technologies peptide microarray 101
a Antibody-mediated neutralization of infection of luciferase-encoding VSV particles pseudotyped with spike proteins of MERS-CoV, SARS-CoV, SARS-CoV-2 and HCoV-OC43. Pseudotyped VSV particles pre-incubated with antibodies at indicated concentrations were used to infect VeroCCL81 cells (MERS-S pseudotyped VSV), VeroE6 cells (SARS-S and SARS2-S pseudotyped VSV) or HRT-18 cells (OC43-S pseudotyped VSV) and luciferase activities in cell lysates were determined at 20 h post transduction to calculate infection (%) relative to non-antibody-treated controls. The average ± SD ( n ≥ 6) from at least two independent experiments performed is shown. Iso-CTRL: an anti-Strep-tag human monoclonal antibody was used as an antibody isotype control. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. b Antibody-mediated neutralization of MERS-CoV, SARS-CoV and SARS-CoV-2 infection. Neutralization of authentic viruses was performed using a plaque reduction neutralization test (PRNT) on VeroCCL81 cells (MERS-CoV) or VeroE6 (SARS-CoV and SARS-CoV-2) as described earlier  ,  . The experiment was performed with triplicate samples, the average ± SD is shown. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. c ELISA-based receptor-binding inhibition assay. MERS-S ecto pre-incubated with serially diluted mAbs was added to ELISA plates coated with soluble human DPP4. The binding of MERS-S ecto to DPP4 was detected using an HRP-conjugated antibody recognizing the C-terminal Strep-tag on MERS-S ecto . Data points represent the average ± SD, for n = 3 replicates from two independent experiments. Source data are provided as a Source Data file. d Cell-cell fusion inhibition assay. Huh-7 cells—transfected with plasmid expressing (GFP-tagged) MERS-CoV S were pre-incubated in the presence or absence of 1.6C7 and 28D9, or an irrelevant iso-type control antibody (Iso-CTRL), and then treated with trypsin to activate the membrane fusion function of the MERS-CoV S protein. The formation of MERS-S mediated syncytia was visualized by fluorescence microscopy. Merged images of MERS-S-GFP expressing cells (green) and DAPI-stained cell nuclei (blue) are shown. The experiment was performed twice, data from a representative experiment is shown. Source data are provided as a Source Data file.
Peptide Microarray 101, supplied by Fluorous Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide microarray 101/product/Fluorous Technologies
Average 90 stars, based on 1 article reviews
peptide microarray 101 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PamGene International B.V microarray peptide assay
a Antibody-mediated neutralization of infection of luciferase-encoding VSV particles pseudotyped with spike proteins of MERS-CoV, SARS-CoV, SARS-CoV-2 and HCoV-OC43. Pseudotyped VSV particles pre-incubated with antibodies at indicated concentrations were used to infect VeroCCL81 cells (MERS-S pseudotyped VSV), VeroE6 cells (SARS-S and SARS2-S pseudotyped VSV) or HRT-18 cells (OC43-S pseudotyped VSV) and luciferase activities in cell lysates were determined at 20 h post transduction to calculate infection (%) relative to non-antibody-treated controls. The average ± SD ( n ≥ 6) from at least two independent experiments performed is shown. Iso-CTRL: an anti-Strep-tag human monoclonal antibody was used as an antibody isotype control. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. b Antibody-mediated neutralization of MERS-CoV, SARS-CoV and SARS-CoV-2 infection. Neutralization of authentic viruses was performed using a plaque reduction neutralization test (PRNT) on VeroCCL81 cells (MERS-CoV) or VeroE6 (SARS-CoV and SARS-CoV-2) as described earlier  ,  . The experiment was performed with triplicate samples, the average ± SD is shown. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. c ELISA-based receptor-binding inhibition assay. MERS-S ecto pre-incubated with serially diluted mAbs was added to ELISA plates coated with soluble human DPP4. The binding of MERS-S ecto to DPP4 was detected using an HRP-conjugated antibody recognizing the C-terminal Strep-tag on MERS-S ecto . Data points represent the average ± SD, for n = 3 replicates from two independent experiments. Source data are provided as a Source Data file. d Cell-cell fusion inhibition assay. Huh-7 cells—transfected with plasmid expressing (GFP-tagged) MERS-CoV S were pre-incubated in the presence or absence of 1.6C7 and 28D9, or an irrelevant iso-type control antibody (Iso-CTRL), and then treated with trypsin to activate the membrane fusion function of the MERS-CoV S protein. The formation of MERS-S mediated syncytia was visualized by fluorescence microscopy. Merged images of MERS-S-GFP expressing cells (green) and DAPI-stained cell nuclei (blue) are shown. The experiment was performed twice, data from a representative experiment is shown. Source data are provided as a Source Data file.
Microarray Peptide Assay, supplied by PamGene International B.V, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray peptide assay/product/PamGene International B.V
Average 90 stars, based on 1 article reviews
microarray peptide assay - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
JPT Peptide Technologies GmbH peptide-microarray slides
a Antibody-mediated neutralization of infection of luciferase-encoding VSV particles pseudotyped with spike proteins of MERS-CoV, SARS-CoV, SARS-CoV-2 and HCoV-OC43. Pseudotyped VSV particles pre-incubated with antibodies at indicated concentrations were used to infect VeroCCL81 cells (MERS-S pseudotyped VSV), VeroE6 cells (SARS-S and SARS2-S pseudotyped VSV) or HRT-18 cells (OC43-S pseudotyped VSV) and luciferase activities in cell lysates were determined at 20 h post transduction to calculate infection (%) relative to non-antibody-treated controls. The average ± SD ( n ≥ 6) from at least two independent experiments performed is shown. Iso-CTRL: an anti-Strep-tag human monoclonal antibody was used as an antibody isotype control. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. b Antibody-mediated neutralization of MERS-CoV, SARS-CoV and SARS-CoV-2 infection. Neutralization of authentic viruses was performed using a plaque reduction neutralization test (PRNT) on VeroCCL81 cells (MERS-CoV) or VeroE6 (SARS-CoV and SARS-CoV-2) as described earlier  ,  . The experiment was performed with triplicate samples, the average ± SD is shown. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. c ELISA-based receptor-binding inhibition assay. MERS-S ecto pre-incubated with serially diluted mAbs was added to ELISA plates coated with soluble human DPP4. The binding of MERS-S ecto to DPP4 was detected using an HRP-conjugated antibody recognizing the C-terminal Strep-tag on MERS-S ecto . Data points represent the average ± SD, for n = 3 replicates from two independent experiments. Source data are provided as a Source Data file. d Cell-cell fusion inhibition assay. Huh-7 cells—transfected with plasmid expressing (GFP-tagged) MERS-CoV S were pre-incubated in the presence or absence of 1.6C7 and 28D9, or an irrelevant iso-type control antibody (Iso-CTRL), and then treated with trypsin to activate the membrane fusion function of the MERS-CoV S protein. The formation of MERS-S mediated syncytia was visualized by fluorescence microscopy. Merged images of MERS-S-GFP expressing cells (green) and DAPI-stained cell nuclei (blue) are shown. The experiment was performed twice, data from a representative experiment is shown. Source data are provided as a Source Data file.
Peptide Microarray Slides, supplied by JPT Peptide Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide-microarray slides/product/JPT Peptide Technologies GmbH
Average 90 stars, based on 1 article reviews
peptide-microarray slides - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


a Antibody-mediated neutralization of infection of luciferase-encoding VSV particles pseudotyped with spike proteins of MERS-CoV, SARS-CoV, SARS-CoV-2 and HCoV-OC43. Pseudotyped VSV particles pre-incubated with antibodies at indicated concentrations were used to infect VeroCCL81 cells (MERS-S pseudotyped VSV), VeroE6 cells (SARS-S and SARS2-S pseudotyped VSV) or HRT-18 cells (OC43-S pseudotyped VSV) and luciferase activities in cell lysates were determined at 20 h post transduction to calculate infection (%) relative to non-antibody-treated controls. The average ± SD ( n ≥ 6) from at least two independent experiments performed is shown. Iso-CTRL: an anti-Strep-tag human monoclonal antibody was used as an antibody isotype control. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. b Antibody-mediated neutralization of MERS-CoV, SARS-CoV and SARS-CoV-2 infection. Neutralization of authentic viruses was performed using a plaque reduction neutralization test (PRNT) on VeroCCL81 cells (MERS-CoV) or VeroE6 (SARS-CoV and SARS-CoV-2) as described earlier  ,  . The experiment was performed with triplicate samples, the average ± SD is shown. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. c ELISA-based receptor-binding inhibition assay. MERS-S ecto pre-incubated with serially diluted mAbs was added to ELISA plates coated with soluble human DPP4. The binding of MERS-S ecto to DPP4 was detected using an HRP-conjugated antibody recognizing the C-terminal Strep-tag on MERS-S ecto . Data points represent the average ± SD, for n = 3 replicates from two independent experiments. Source data are provided as a Source Data file. d Cell-cell fusion inhibition assay. Huh-7 cells—transfected with plasmid expressing (GFP-tagged) MERS-CoV S were pre-incubated in the presence or absence of 1.6C7 and 28D9, or an irrelevant iso-type control antibody (Iso-CTRL), and then treated with trypsin to activate the membrane fusion function of the MERS-CoV S protein. The formation of MERS-S mediated syncytia was visualized by fluorescence microscopy. Merged images of MERS-S-GFP expressing cells (green) and DAPI-stained cell nuclei (blue) are shown. The experiment was performed twice, data from a representative experiment is shown. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

doi: 10.1038/s41467-021-21968-w

Figure Lengend Snippet: a Antibody-mediated neutralization of infection of luciferase-encoding VSV particles pseudotyped with spike proteins of MERS-CoV, SARS-CoV, SARS-CoV-2 and HCoV-OC43. Pseudotyped VSV particles pre-incubated with antibodies at indicated concentrations were used to infect VeroCCL81 cells (MERS-S pseudotyped VSV), VeroE6 cells (SARS-S and SARS2-S pseudotyped VSV) or HRT-18 cells (OC43-S pseudotyped VSV) and luciferase activities in cell lysates were determined at 20 h post transduction to calculate infection (%) relative to non-antibody-treated controls. The average ± SD ( n ≥ 6) from at least two independent experiments performed is shown. Iso-CTRL: an anti-Strep-tag human monoclonal antibody was used as an antibody isotype control. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. b Antibody-mediated neutralization of MERS-CoV, SARS-CoV and SARS-CoV-2 infection. Neutralization of authentic viruses was performed using a plaque reduction neutralization test (PRNT) on VeroCCL81 cells (MERS-CoV) or VeroE6 (SARS-CoV and SARS-CoV-2) as described earlier , . The experiment was performed with triplicate samples, the average ± SD is shown. The IC 50 and IC 90 values were shown. Source data are provided as a Source Data file. c ELISA-based receptor-binding inhibition assay. MERS-S ecto pre-incubated with serially diluted mAbs was added to ELISA plates coated with soluble human DPP4. The binding of MERS-S ecto to DPP4 was detected using an HRP-conjugated antibody recognizing the C-terminal Strep-tag on MERS-S ecto . Data points represent the average ± SD, for n = 3 replicates from two independent experiments. Source data are provided as a Source Data file. d Cell-cell fusion inhibition assay. Huh-7 cells—transfected with plasmid expressing (GFP-tagged) MERS-CoV S were pre-incubated in the presence or absence of 1.6C7 and 28D9, or an irrelevant iso-type control antibody (Iso-CTRL), and then treated with trypsin to activate the membrane fusion function of the MERS-CoV S protein. The formation of MERS-S mediated syncytia was visualized by fluorescence microscopy. Merged images of MERS-S-GFP expressing cells (green) and DAPI-stained cell nuclei (blue) are shown. The experiment was performed twice, data from a representative experiment is shown. Source data are provided as a Source Data file.

Article Snippet: Spike protein peptide microarray analysis to map linear epitopes of antibodies in convalescent sera was performed by PEPSCAN (Lelystad, The Netherlands).

Techniques: Neutralization, Infection, Luciferase, Incubation, Transduction, Strep-tag, Control, Plaque Reduction Neutralization Test, Enzyme-linked Immunosorbent Assay, Binding Assay, Inhibition, Transfection, Plasmid Preparation, Expressing, Membrane, Fluorescence, Microscopy, Staining

a Antibody binding competition analysed by biolayer interferometry. Immobilized MERS-S ecto antigen was saturated in binding with a given mAb (step 1) and then exposed to binding by a second mAb (step 2). Additional binding of the second antibody indicates the presence of an unoccupied epitope, whereas lack of binding indicates epitope blocking by mAb1. As a control, the first mAb was also included in the second step to check for self-competition. The competitive binding was tested for the S2-targeting 1.6C7 and 28D9 antibodies and a MERS-S1 antibody control (7.7G6)  . Source data are provided as a Source Data file. b 1.6C7 and 28D9 recognize a linear epitope. ELISA binding curves of 1.6C7 and 28D9 to untreated MERS-S ecto (non-denatured: ‘nd’) versus MERS-S ecto that was heat-denatured in the presence of SDS and DTT (denatured: ‘d’). Two antibodies targeting the MERS-S1 domain (7.7G6) and the 8-residue long linear Strep-tag epitope (anti-strep) were used as controls. Source data are provided as a Source Data file. c 1.6C7/28D9 epitope maps to a 15-aa long stem region upstream of HR2 in MERS-S. ELISA-reactivity of 1.6C7 and 28D9 to a peptide library of 30-amino acid long peptides (with 15-a.a. overlap) covering the conserved C-terminal part of the MERS-S ecto (residues 869-1,288). Both antibodies reacted with two peptides (blue and orange bars), and with a peptide corresponding to their 15-a.a. long overlap (green bar; MERS-S residues 1,229–1,243). The position of the epitope containing region is indicated in the MERS-S protein schematic with the spike subunits (S1 and S2), S1 domains (A through D), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2) and transmembrane domain (TM) annotated. Source data are provided as a Source Data file. d The 1.6C7/28D9 epitope maps to a 8-aa long peptide ‘DELDEFFK’ detected by ELISA. ELISA binding curves of 1.6C7 and 28D9 to N- and C-terminally truncated versions of the 15-mer peptide fragment of MERS-S. Data points represent the average from n = 2 technical replicates. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

doi: 10.1038/s41467-021-21968-w

Figure Lengend Snippet: a Antibody binding competition analysed by biolayer interferometry. Immobilized MERS-S ecto antigen was saturated in binding with a given mAb (step 1) and then exposed to binding by a second mAb (step 2). Additional binding of the second antibody indicates the presence of an unoccupied epitope, whereas lack of binding indicates epitope blocking by mAb1. As a control, the first mAb was also included in the second step to check for self-competition. The competitive binding was tested for the S2-targeting 1.6C7 and 28D9 antibodies and a MERS-S1 antibody control (7.7G6) . Source data are provided as a Source Data file. b 1.6C7 and 28D9 recognize a linear epitope. ELISA binding curves of 1.6C7 and 28D9 to untreated MERS-S ecto (non-denatured: ‘nd’) versus MERS-S ecto that was heat-denatured in the presence of SDS and DTT (denatured: ‘d’). Two antibodies targeting the MERS-S1 domain (7.7G6) and the 8-residue long linear Strep-tag epitope (anti-strep) were used as controls. Source data are provided as a Source Data file. c 1.6C7/28D9 epitope maps to a 15-aa long stem region upstream of HR2 in MERS-S. ELISA-reactivity of 1.6C7 and 28D9 to a peptide library of 30-amino acid long peptides (with 15-a.a. overlap) covering the conserved C-terminal part of the MERS-S ecto (residues 869-1,288). Both antibodies reacted with two peptides (blue and orange bars), and with a peptide corresponding to their 15-a.a. long overlap (green bar; MERS-S residues 1,229–1,243). The position of the epitope containing region is indicated in the MERS-S protein schematic with the spike subunits (S1 and S2), S1 domains (A through D), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2) and transmembrane domain (TM) annotated. Source data are provided as a Source Data file. d The 1.6C7/28D9 epitope maps to a 8-aa long peptide ‘DELDEFFK’ detected by ELISA. ELISA binding curves of 1.6C7 and 28D9 to N- and C-terminally truncated versions of the 15-mer peptide fragment of MERS-S. Data points represent the average from n = 2 technical replicates. Source data are provided as a Source Data file.

Article Snippet: Spike protein peptide microarray analysis to map linear epitopes of antibodies in convalescent sera was performed by PEPSCAN (Lelystad, The Netherlands).

Techniques: Binding Assay, Blocking Assay, Control, Enzyme-linked Immunosorbent Assay, Residue, Strep-tag

a Schematic representation of the MERS-CoV spike protein. The spike subunits (S1 and S2), S1 domains (A through D), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2) and transmembrane domain (TM) are annotated. b Spike protein peptide microarray analysis using MERS-positive human and dromedary camel sera. 905 overlapping peptides covering the entire MERS-CoV S ectodomain (residues 1–1296) were synthesized with an offset of one or two residues. The binding of five convalescent MERS-positive human (H1–H5) and four dromedary camel (D1–D4) sera to the peptide library, as well as a MERS-negative serum from human (H-CTRL) or camel (D-CTRL) was assessed in a PEPSCAN-based ELISA (Lelystad, The Netherlands). A cumulative heatmap of signal intensities for individual peptides are shown. Signal intensities increase from light reddish to red, whereas white corresponds to background signal. Source data are provided as a Source Data file. c Reactivity of the human and dromedary sera to peptides covering the 1.6C7/28D9 epitope region (epitope core sequence highlighted in red). Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

doi: 10.1038/s41467-021-21968-w

Figure Lengend Snippet: a Schematic representation of the MERS-CoV spike protein. The spike subunits (S1 and S2), S1 domains (A through D), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2) and transmembrane domain (TM) are annotated. b Spike protein peptide microarray analysis using MERS-positive human and dromedary camel sera. 905 overlapping peptides covering the entire MERS-CoV S ectodomain (residues 1–1296) were synthesized with an offset of one or two residues. The binding of five convalescent MERS-positive human (H1–H5) and four dromedary camel (D1–D4) sera to the peptide library, as well as a MERS-negative serum from human (H-CTRL) or camel (D-CTRL) was assessed in a PEPSCAN-based ELISA (Lelystad, The Netherlands). A cumulative heatmap of signal intensities for individual peptides are shown. Signal intensities increase from light reddish to red, whereas white corresponds to background signal. Source data are provided as a Source Data file. c Reactivity of the human and dromedary sera to peptides covering the 1.6C7/28D9 epitope region (epitope core sequence highlighted in red). Source data are provided as a Source Data file.

Article Snippet: Spike protein peptide microarray analysis to map linear epitopes of antibodies in convalescent sera was performed by PEPSCAN (Lelystad, The Netherlands).

Techniques: Peptide Microarray, Synthesized, Binding Assay, Enzyme-linked Immunosorbent Assay, Sequencing